Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toward the elimination of hepatitis B: networking to promote the prevention of vertical transmission of hepatitis B virus through population-based interventions and multidisciplinary groups in Africa.
Torimiro JNE, Duri K, Goumkwa NM, Atah SM, Ndzie Ondigui JL, Lobe C, Bouyou M, Ndeboko B, Mahamat Moussa A, Police C, Awoumou P, Peyonga P, Djivida PV, Felix A, Nchinda GW, Wandji B, Simo RK, Agnès Moudourou S, Gutierrez A, Garcia R, Fernandez I, Mah E, Rowland-Jones S, Mbu R. Torimiro JNE, et al. Front Public Health. 2024 Apr 5;12:1283350. doi: 10.3389/fpubh.2024.1283350. eCollection 2024. Front Public Health. 2024. PMID: 38645447 Free PMC article.
Epidemiology of occult hepatitis B and C in Africa: A systematic review and meta-analysis.
Ondigui JLN, Kenmoe S, Kengne-Ndé C, Ebogo-Belobo JT, Takuissu GR, Kenfack-Momo R, Mbaga DS, Tchatchouang S, Kenfack-Zanguim J, Fogang RL, Menkem EZ, Kame-Ngasse GI, Magoudjou-Pekam JN, Bowo-Ngandji A, Goumkwa NM, Esemu SN, Ndip L, Essama SHR, Torimiro J. Ondigui JLN, et al. J Infect Public Health. 2022 Dec;15(12):1436-1445. doi: 10.1016/j.jiph.2022.11.008. Epub 2022 Nov 12. J Infect Public Health. 2022. PMID: 36395668 Free PMC article.
Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus.
Matthews PC, Ocama P, Wang S, El-Sayed M, Turkova A, Ford D, Torimiro J, Garcia Ferreira AC, Espinosa Miranda A, De La Hoz Restrepo FP, Seremba E, Mbu R, Pan CQ, Razavi H, Dusheiko G, Spearman CW, Hamid S. Matthews PC, et al. JHEP Rep. 2023 Apr 24;5(8):100777. doi: 10.1016/j.jhepr.2023.100777. eCollection 2023 Aug. JHEP Rep. 2023. PMID: 37554925 Free PMC article. Review.
Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population.
Sosso SM, Tchouaket MCT, Fokam J, Simo RK, Semengue ENJ, Sando Z, Torimiro J, Tiga A, Lobe EE, Ambada G, Nange A, Nka AD, Chenwi C, Abba A, Ka'e AC, Fainguem N, Zam MKN, Yagai B, Billong SC, Colizzi V, Ndjolo A. Sosso SM, et al. J Public Health Afr. 2023 Oct 1;14(9):2334. doi: 10.4081/jphia.2023.2334. eCollection 2023 Oct 1. J Public Health Afr. 2023. PMID: 37942060 Free PMC article.
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection.
Delphin M, Mohammed KS, Downs LO, Lumley SF, Waddilove E, Okanda D, Aliyan N, Van Schalkwyk M, Anderson M, Ocama P, Maponga T, Torimiro J, Iwuji C, Ndung'u T, Matthews PC, Taljaard J. Delphin M, et al. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):383-392. doi: 10.1016/S2468-1253(23)00315-1. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367632 Review.
Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?".
Matthews PC, Ocama P, Wang S, El-Sayed M, Turkova A, Ford D, Torimiro J, Garcia Ferreira AC, Miranda AE, De La Hoz Restrepo FP, Seremba E, Mbu R, Pan CQ, Razavi H, Dusheiko G, Spearman CW, Hamid S. Matthews PC, et al. JHEP Rep. 2023 Aug 7;5(11):100875. doi: 10.1016/j.jhepr.2023.100875. eCollection 2023 Nov. JHEP Rep. 2023. PMID: 37822785 Free PMC article. No abstract available.
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance.
Abdullahi A, Diaz AG, Fopoussi OM, Beloukas A, Defo VF, Kouanfack C, Torimiro J, Geretti AM. Abdullahi A, et al. J Antimicrob Chemother. 2024 Feb 1;79(2):339-348. doi: 10.1093/jac/dkad386. J Antimicrob Chemother. 2024. PMID: 38153241 Free PMC article. Clinical Trial.